Predict your next investment

Venture Capital
healthinvestequity.com

See what CB Insights has to offer

Investments

17

Portfolio Exits

5

Funds

9

Service Providers

1

About HealthInvest Equity Partners

HealthInvest Equity Partners ("HealthInvest") is an investment firm focused on starting and growing successful healthcare businesses. The principals of the firm have invested in many successful healthcare services companies at all stages of development.

HealthInvest Equity Partners Headquarter Location

1055 Washington Boulevard 6th Floor

Stamford, Connecticut, 6901,

United States

203-324-7700

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest HealthInvest Equity Partners News

Genome Medical Raises $14M in Funding

Jul 1, 2020

Genome Medical , a South San Francisco, CA-based telegenomics technology and services company democratizing access to genomic-based medicine, raised $14m in Series B extension funding. This round, which brought the total capital raised since 2016 to $60m, was led by Samsung Catalyst Fund, with participation from Chairman and Co-founder Randy Scott, Canaan Partners, Illumina Ventures, Echo Health Ventures, Perceptive Advisors, LRVHealth, Kaiser Permanente Ventures, Avestria Ventures, Casdin Capital, HealthInvest Equity Partners, Revelation Partners, Dreamers Fund, Flywheel Ventures and Manatt Ventures. The company intends to use the funds to accelerated development of the Genome Care DeliveryTM technology platform for cancer, reproductive health and pharmacogenomics. Led by Lisa Alderson, CEO and Co-founder, Genome Medical Genome Medical is a national telegenomics technology, services and strategy company bringing genomic medicine to everyday care. Through a nationwide network of genetic specialists and efficient Genome Care Delivery technology platform, the company provides expert virtual genetic care for individuals and their families to improve health and well-being. It also helps health care providers and their patients navigate the field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. Genome Medical’s solutions are utilized by health systems, hospitals, payors, providers and employers to expand access to genetic health services. The company also services patients directly and accepts self-referrals. FinSMEs 01/07/2020

HealthInvest Equity Partners Investments

17 Investments

HealthInvest Equity Partners has made 17 investments. Their latest investment was in Genome Medical as part of their Series C on August 8, 2021.

CBI Logo

HealthInvest Equity Partners Investments Activity

investments chart

HealthInvest Equity Partners Portfolio Exits

5 Portfolio Exits

HealthInvest Equity Partners has 5 portfolio exits. Their latest portfolio exit was Cellular Genomics on July 08, 2010.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/8/2010

Acquired

1

6/25/2010

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

2/28/1996

IPO

Subscribe to see more

Subscribe to see more

10

7/31/1983

IPO

Subscribe to see more

Subscribe to see more

10

12/31/1981

IPO

Subscribe to see more

Subscribe to see more

10

Date

7/8/2010

6/25/2010

2/28/1996

7/31/1983

12/31/1981

Exit

Acquired

Acquired

IPO

IPO

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

1

10

10

10

10

HealthInvest Equity Partners Acquisitions

1 Acquisition

HealthInvest Equity Partners acquired 1 company. Their latest acquisition was DNA Plant Technology on December 31, 1984.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

12/31/1984

Series A

$99M

IPO

1

Date

12/31/1984

Investment Stage

Series A

Companies

Valuation

$99M

Total Funding

Note

IPO

Sources

1

HealthInvest Equity Partners Fund History

9 Fund Histories

HealthInvest Equity Partners has 9 funds, including CHL Medical Partners III LP.

Closing Date

Fund

Fund Type

Status

Amount

Sources

12/31/2007

CHL Medical Partners III LP

Early-Stage Venture Capital

Closed

$120M

1

12/31/2002

CHL Medical Partners II LP

Subscribe to see more

Subscribe to see more

$99M

10

12/31/1998

CHL Medical Partners LP

Subscribe to see more

Subscribe to see more

$99M

10

1/1/1995

Biotechnology Investment Group LLC

Subscribe to see more

Subscribe to see more

$99M

10

1/1/1989

Schroder Ventures

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

12/31/2007

12/31/2002

12/31/1998

1/1/1995

1/1/1989

Fund

CHL Medical Partners III LP

CHL Medical Partners II LP

CHL Medical Partners LP

Biotechnology Investment Group LLC

Schroder Ventures

Fund Type

Early-Stage Venture Capital

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Closed

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$120M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

HealthInvest Equity Partners Service Providers

1 Service Provider

HealthInvest Equity Partners has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

Partnership data by VentureSource

HealthInvest Equity Partners Team

4 Team Members

HealthInvest Equity Partners has 4 team members, including current Chief Financial Officer, Steve Moskowitz.

Name

Work History

Title

Status

Steve Moskowitz

Chief Financial Officer

Current

Myles D Greenberg

Pappas Ventures

Managing Principal

Current

Timothy F Howe

Managing Principal

Current

Gregory M Weinhoff

Managing Principal

Current

Name

Steve Moskowitz

Myles D Greenberg

Timothy F Howe

Gregory M Weinhoff

Work History

Pappas Ventures

Title

Chief Financial Officer

Managing Principal

Managing Principal

Managing Principal

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.